AdvaMed® creates industry standards and white papers relevant to medical imaging technology, including X-Ray, CT, Ultrasound, MR, and molecular imaging modalities. AdvaMed® is dedicated to ensuring standards and industry-leading white papers address the manufacturers’ needs as new technologies are developed in an ever-changing marketplace.
Submit your interest in learning more information about AdvaMed®’s Standards.
Related Reading
News / Medical Imaging
AdvaMed Releases White Paper on Medical Imaging Cybersecurity
August 7, 2025
WASHINGTON, DC—AdvaMed, the medtech association, recently published a technical performance and safety white paper titled “Medical Imaging Device Cybersecurity: Critical Outage Situations and Response.” The white paper outlines common imaging device outage scenarios and manufacturers’ recommended steps for hospitals and radiology departments to consider in order to both mitigate the cyberattack’s impact and keep medical imaging systems functioning for physicians and patients.
News / Diagnostics / Digital Health / Government & Legislative Affairs / Medical Imaging / Regulatory Affairs
AdvaMed Welcomes MDUFA VI Discussion Kickoff at FDA Public Meeting
August 4, 2025
WASHINGTON, D.C.—AdvaMed, the medtech association, today welcomed the kickoff of the latest Medical Device User Fee Amendments (MDUFA) discussion at a public meeting at FDA headquarters. Three AdvaMed senior staff members encouraged the agency to build on the successes of the prior five such agreements to ensure the next agreement, MDUFA VI, delivers strong results for the American public.
News / Diagnostics / Digital Health / Government & Legislative Affairs / Medical Imaging
AdvaMed Welcomes White House’s “America’s AI Action Plan”
July 23, 2025
WASHINGTON, D.C.—Scott Whitaker, president and CEO of AdvaMed, the medtech association, issued the following statement on the White House’s “America’s AI Action Plan”:
Blog / Diabetes / Diagnostics / Digital Health / Medical Imaging / Orthopedic / Radiation Therapy
Advancing Access to Patient Care: The Importance of Advocacy on the Hill
July 10, 2025
AdvaMed’s 2024 Medtech Showcase on Capitol Hill featured 37 companies and 40+ innovations, connecting medtech leaders with U.S. policymakers.
Blog / Diabetes / Diagnostics / Digital Health / Government & Legislative Affairs / Medical Imaging / Orthopedic / Radiation Therapy
Medtech Goes to Capitol Hill
June 26, 2025
AdvaMed’s annual Medtech Showcase and Reception on Capitol Hill seeks to inform a core audience: the members of the Congress and their staff who enact the policies that help our member companies reach patients with their transformative medtech.
News / Medical Imaging
Cardiawave Announces Positive 12-Month Results from Its “Valvosoft® FIM Study” and “Valvosoft® Pivotal Study” for the Treatment of Severe Symptomatic Aortic Stenosis (sSAS)
May 30, 2025
Levallois-Perret, France – May 22, 2025 — Cardiawave SA, medtech company specialized in valvular heart disease, presented today at the EuroPCR Congress the 12-month results from its “Valvosoft® FIM Study” and “Valvosoft® Pivotal Study” evaluating its innovative non-invasive ultrasound therapy (NIUT) device for the treatment of Severe Symptomatic Aortic Stenosis (sSAS).
Resource / Digital Health / Government & Legislative Affairs / Medical Imaging
AI Policy Roadmap
March 14, 2025
Discover how AI is transforming medical technology with the AI Policy Roadmap. Learn how Congress can unleash even more innovation with targeted legislation. Download your copy today!
Blog / Medical Imaging
AdvaMed Imaging® Celebrates Major Milestones in 2024, Lays Groundwork for 2025
February 3, 2025
Recap AdvaMed®’s Medical Imaging Divisions achievements for members and the industry during its inaugural year with the medtech association.